arsenic has been researched along with naphthoquinones in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ganapathy, V; Leibach, FH; Miyamoto, Y; Tiruppathi, C | 1 |
| Kuo, JF | 1 |
| Neuhaus, JM; Wright, JK | 1 |
| Konings, WN; Robillard, GT | 1 |
| Gao, F; Li, H; Shi, G; Shi, X; Tang, X; Wang, Z; Yi, J | 2 |
| Gao, F; Shi, GY; Tang, XM; Yi, J; Yuan, JQ | 1 |
| Chen, M; Cheng, X; Fan, X; Ji, J; Song, J; Wu, F; Ying, X; Zhang, D; Zhao, Z | 1 |
1 review(s) available for arsenic and naphthoquinones
| Article | Year |
|---|---|
Effects of insulin and substances having insulin-like activity on adipose cells: sugar utilization, lipolysis, adenyl cyclase-cyclic AMP system and cyclic AMP-dependent protein kinase.
Topics: Adenylyl Cyclases; Adipose Tissue; Antifungal Agents; Arsenic; Cyclic AMP; Enzyme Activation; Fatty Acids; Glucose; Insulin; Lactones; Lipid Mobilization; Naphthols; Naphthoquinones; Natamycin; Nystatin; Peptide Hydrolases; Phosphotransferases; Proteins; Receptors, Drug; Valinomycin; Vitamin K | 1970 |
8 other study(ies) available for arsenic and naphthoquinones
| Article | Year |
|---|---|
[Committee on anthelmintics. Residual group].
Topics: Animals; Anthelmintics; Arecoline; Arsenicals; Bithionol; Dichlorophen; Helminthiasis; Helminthiasis, Animal; Hexachlorophene; Mebendazole; Naphthoquinones; Niclofolan; Organophosphorus Compounds; Paromomycin; Piperidines; Plant Extracts; Rafoxanide; Thiocyanates; Toluidines | 1975 |
Involvement of thiol groups in the function of the dipeptide/proton cotransport system in rabbit renal brush-border membrane vesicles.
Topics: Animals; Arsenicals; Biological Transport; Carrier Proteins; Dimercaprol; Dipeptides; Dithionitrobenzoic Acid; Kidney Cortex; Kinetics; Methylphenazonium Methosulfate; Microvilli; Naphthoquinones; Oxidation-Reduction; Protons; Rabbits; Structure-Activity Relationship; Sulfhydryl Compounds | 1989 |
Chemical modification of the lactose carrier of Escherichia coli by plumbagin, phenylarsinoxide or diethylpyrocarbonate affects the binding of galactoside.
Topics: Arsenicals; Binding Sites; Biological Transport; Chemical Phenomena; Chemistry; Diethyl Pyrocarbonate; Escherichia coli; Escherichia coli Proteins; Formates; Galactosides; Glycosides; Membrane Transport Proteins; Monosaccharide Transport Proteins; Naphthoquinones; Protein Binding; Symporters | 1983 |
Physical mechanism for regulation of proton solute symport in Escherichia coli.
Topics: Arsenicals; Biological Transport, Active; Dithiothreitol; Escherichia coli; Escherichia coli Proteins; Kinetics; Lactose; Membrane Transport Proteins; Monosaccharide Transport Proteins; Naphthoquinones; Oxidation-Reduction; Proline; Sulfhydryl Reagents; Symporters | 1982 |
The inherent cellular level of reactive oxygen species: one of the mechanisms determining apoptotic susceptibility of leukemic cells to arsenic trioxide.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Separation; Dose-Response Relationship, Drug; Flow Cytometry; Humans; In Situ Nick-End Labeling; Leukemia, Myeloid; Naphthoquinones; Oxides; Reactive Oxygen Species; Tumor Cells, Cultured | 2002 |
[Ascorbic acid enhances the apoptosis of U937 cells induced by arsenic trioxide in combination with DMNQ and its mechanism].
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Ascorbic Acid; Drug Synergism; Flow Cytometry; Humans; Naphthoquinones; Oxides; U937 Cells | 2002 |
The cell cycle related apoptotic susceptibility to arsenic trioxide is associated with the level of reactive oxygen species.
Topics: Acetylcysteine; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Catalase; Cell Cycle; Cell Division; Cell Line, Tumor; Dactinomycin; Flow Cytometry; Fluoresceins; Humans; In Situ Nick-End Labeling; Interphase; Naphthoquinones; Oxides; Propidium; Reactive Oxygen Species | 2004 |
Shikonin potentiates the effect of arsenic trioxide against human hepatocellular carcinoma in vitro and in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; DNA Damage; Drug Synergism; Endoplasmic Reticulum Stress; Hep G2 Cells; Humans; Liver Neoplasms; Mice, Nude; Naphthoquinones; Oxides; Xenograft Model Antitumor Assays | 2016 |